Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 277

DECLARATION re #275 MOTION to Determine the Sufficiency of Roche's Responses to Amgen's Requests for Admission of Krista M. Carter by Amgen Inc.. (Attachments: #1 Confidential Exhibits Coversheet#2 Exhibit 1#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 12)(Gottfried, Michael)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 277 Att. 6

Case 1:05-cv-12237-WGY

Document 277-7

Filed 02/13/2007

Page 1 of 2

EXHIBIT 6

Dockets.Justia.com

Case 1:05-cv-12237-WGY Document 277-7 Filed 02/13/2007 Page 2 of 2

DAY CASEBEER MADRID & BATCHELDER LLP

20300 Stevens Creek Blvd., Suite 400 Cupertino, CA 95014 Telephone : [phone] Facsimile : [phone]

Krista M . Carter [phone] kcarter@daycasebeer .com

January 22, 2007
VIA EMAIL & FACSIMILE

Patricia A. Carson, Esq. Kaye Scholer LLP 425 Park Avenue New York, NY 10022-3598 Re :
Amgen Inc. v. F. Hoffmann-La Roche Ltd., et al. (05-CV-12237WGY)

Dear Pat: I write to follow-up on my letter to you dated January 18 . I have not seen a response from you or any of your colleagues as to whether Roche agrees to supplement its responses to Amgen's Requests for Admission and, if so, which Requests for Admission Roche agrees to supplement . As I stated in my last correspondence, Roche's demand for an additional 30 days is both unnecessary and unreasonable . Amgen is unwilling to allow Roche additional time to respond to its Requests without assurances that those responses will be fulsome and timely . I assume from your silence that Roche is unwilling to provide straightforward and complete supplemental responses or to discuss a reasonable schedule for such supplementation . Please let me know immediately if I am incorrect.

Sincerely,
DAY CASEBEER MADRID & BATCHELDER LLP

Krista M. Carter KMC :par cc : Howard Suh Thomas F. Fleming Michele Moreland Mark Izraelewicz